Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex

Cerebral Cortex

Volumn 20, Issue 5, 2010, Pages 1164-1174

  Eggan, Stephen M ^a   Mizoguchi, Yoshito ^a   Stoyak, Samuel R ^a   Lewis, David A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cholecystokinin; GABA; Interneurons; Parvalbumin; Schizophrenia

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABIS; MESSENGER RNA;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EXPOSURE; FEMALE; GRAY MATTER; IMMUNOREACTIVITY; MACACA; MALE; MATURATION; MENTAL DISEASE; MONKEY; NEWBORN; NONHUMAN; PERINATAL PERIOD; PREFRONTAL CORTEX; PRIMATE; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; SCHIZOPHRENIA;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; EMBRYO, MAMMALIAN; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MACACA NEMESTRINA; MALE; PREFRONTAL CORTEX; RECEPTOR, CANNABINOID, CB1; RNA, MESSENGER;

EID: 77951128954     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhp179     Document Type: Article

References (73)

1. Alexander GE, Goldman PS. 1978. Functional development of the dorsolateral prefrontal cortex: an analysis utilizing reversible cryogenic depression. Brain Res. 143:233-249.
2. Anderson SA, Classey JD, Conde F, Lund JS, Lewis DA. 1995. Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience. 67:7-22.
3. Bacci A, Huguenard JR, Prince DA. 2004. Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature. 431:312-316.
4. Barbas H, Pandya DN. 1989. Architecture and intrinsic connections of the prefrontal cortex in the rhesus monkey. J Comp Neurol. 286:353-375.
5. Ben-Ari Y. 2002. Excitatory actions of GABA during development: the nature of the nurture. Nat Rev Neurosci. 3:728-739. (Pubitemid 135706678)
6. Berghuis P, Dobszay MB, Wang X, Spano S, Ledda F, Sousa KM, Schulte G, Ernfors P, Mackie K, Paratcha G, et al. 2005. Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proc Natl Acad Sci USA. 102:19115-19120.
7. Berghuis P, Rajnicek AM, Morozov YM, Ross RA, Mulder J, Urban GM, Monory K, Marsicano G, Matteoli M, Canty A, et al. 2007. Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science. 316:1212-1216.
8. Bernard C, Milh M, Morozov YM, Ben Ari Y, Freund TF, Gozlan H. 2005. Altering cannabinoid signaling during development disrupts neuro-nal activity. Proc Natl Acad Sci USA. 102:9388-9393.
9. Berrendero F, Sepe N, Ramos JA, Di MV, Fernandez-Ruiz JJ. 1999. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse. 33:181-191.
10. Bodor AL, Katona I, Nyiri G, Mackie K, Ledent C, Hajos N, Freund TF. 2005. Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci. 25:6845-6856.
11. Bourgeois J-P, Goldman-Rakic PS, Rakic P. 1994. Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb Cortex. 4:78-96.
12. Carter E, Wang XJ. 2007. Cannabinoid-mediated disinhibition and working memory: dynamical interplay of multiple feedback mechanisms in a continuous attractor model of prefrontal cortex. Cereb Cortex. 17(Suppl 1):i16-i26.
13. Chattopadhyaya B, Di Cristo G, Wu CZ, Knott G, Kuhlman S, Fu Y, Palmiter RD, Huang ZJ. 2007. GAD67-mediated GABA synthesis and signaling regulate inhibitory synaptic innervation in the visual cortex. Neuron. 54:889-903.
14. Chevaleyre V, Takahashi KA, Castillo PE. 2006. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci. 29:37-76.
15. Conde F, Lund JS, Lewis DA. 1996. The hierarchical development of monkey visual cortical regions as revealed by the maturation of parvalbumin- immunoreactive neurons. Dev Brain Res. 96:261-276.
16. Cruz DA, Eggan SM, Lewis DA. 2003. Postnatal development of pre-and post-synaptic GABA markers at chandelier cell inputs to pyramidal neurons in monkey prefrontal cortex. J Comp Neurol. 465:385-400.
17. Cruz DA, Lovallo EM, Stockton S, Rasband M, Lewis DA. 2009. Postnatal development of synaptic structure proteins in pyramidal neuron axon initial segments in monkey prefrontal cortex. J Comp Neurol. 514:353-367.
18. Deshmukh S, Onozuka K, Bender KJ, Bender VA, Lutz B, Mackie K, Feldman DE. 2007. Postnatal development of cannabinoid receptor type 1 expression in rodent somatosensory cortex. Neuroscience. 145:279-287.
19. Diamond A. 2002. Normal development of prefrontal cortex from birth to young adulthood: cognitive functions, anatomy and biochemistry. In: Stuss DT, Knight RT, editors. Principles of frontal lobe function. London: Oxford University Press. p. 466-503.
20. Egerton A, Allison C, Brett RR, Pratt JA. 2006. Cannabinoids and prefrontal cortical function: insights from preclinical studies. Neurosci Biobehav Rev. 30:680-695.
21. Eggan SM, Hashimoto T, Lewis DA. 2008. Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Arch Gen Psychiatry. 65:772-784.
22. Eggan SM, Lewis DA. 2007. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex. 17:175-191.
23. Erickson SL, Akil M, Levey AI, Lewis DA. 1998. Postnatal development of tyrosine hydroxylase-and dopamine transporter-immunoreactive axons in monkey rostral entorhinal cortex. Cereb Cortex. 8:415-427.
24. Erickson SL, Lewis DA. 2002. Postnatal development of parvalbumin-and GABA transporter-immunoreactive axon terminals in monkey prefrontal cortex. J Comp Neurol. 448:186-202.
25. Fernandez-Ruiz J, Berrendero F, Hernaandez ML, Ramos JA. 2000. The endogenous cannabinoid system and brain development. Trends Neurosci. 23:14-20.
26. Foldy C, Lee SY, Szabadics J, Neu A, Soltesz I. 2007. Cell type-specific gating of perisomatic inhibition by cholecystokinin. Nat Neurosci. 10:1128-1130.
27. Foldy C, Neu A, Jones MV, Soltesz I. 2006. Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J Neurosci. 26:1465-1469.
28. Freund TF. 2003. Interneuron diversity series: rhythm and mood in perisomatic inhibition. Trends Neurosci. 26:489-495.
29. Freund TF, Katona I, Piomelli D. 2003. Role of endogenous cannabi-noids in synaptic signaling. Physiol Rev. 83:1017-1066.
30. Fride E. 2004. The endocannabinoid-CB(1) receptor system in pre-and postnatal life. Eur J Pharmacol. 500:289-297.
31. Galarreta M, Erdelyi F, Szabo G, Hestrin S. 2004. Electrical coupling among irregular-spiking GABAergic interneurons expressing canna-binoid receptors. J Neurosci. 24:9770-9778.
32. Glickfeld LL, Scanziani M. 2006. Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells. Nat Neurosci. 9:807-815.
33. Goldman PS. 1971. Functional development of the prefrontal cortex in early life and the problem of neuronal plasticity. Exp Neurol. 32:366-387.
34. Goldman-Rakic PS. 1995. Cellular basis of working memory. Neuron. 14:477-485.
35. Gonzalez-Burgos G, Kroener S, Zaitsev AV, Povysheva NV, Krimer LS, Barrionuevo G, Lewis DA. 2008. Functional maturation of excitatory synapses in layer 3 pyramidal neurons during postnatal development of the primate prefrontal cortex. Cereb Cortex. 18:626-637.
36. Gruber AJ, Pope HG. 2002. Marijuana use among adolescents. Pediatr Clin North Am. 49:389-413.
37. Hajos N, Katona I, Naiem SS, Mackie K, Ledent C, Mody I, Freund TF. 2000. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci. 12:3239-3249.
38. Hashimoto T, Nguyen QL, Rotaru D, Keenan T, Arion D, Beneyto M, Gonzalez-Burgos G, Lewis DA. 2009. Protracted developmental trajectories of GABAA receptor alpha1 and alpha2 subunit expression in primate prefrontal cortex. Biol Psychiatry. 65:1015-1023.
39. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA. 2003. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci. 23:6315-6326.
40. Howard MW, Rizzuto DS, Caplan JB, Madsen JR, Lisman J, Aschen-brenner-Scheibe R, Schulze-Bonhage A, Kahana MJ. 2003. Gamma oscillations correlate with working memory load in humans. Cereb Cortex. 13:1369-1374.
41. Jung AB, Bennett JP. 1996. Development of striatal dopaminergic function.1. Pre-and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors. Brain Res Dev Brain Res. 94:109-120.
42. Karson MA, Tang AH, Milner TA, Alger BE. 2009. Synaptic cross talk between perisomatic-targeting interneuron classes expressing cholecystokinin and parvalbumin in hippocampus. J Neurosci. 29:4140-4154.
43. Karson MA, Whittington KC, Alger BE. 2008. Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others. Neuropharmacology. 54:117-128.
44. Katona I, Sperlagh B, Magloczky Z, Santha E, Kofalvi A, Czirjak S, Mackie K, Vizi ES, Freund TF. 2000. GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience. 100:797-804.
45. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, Freund TF. 1999. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci. 19:4544-4558.
46. Katona I, Urban GM, Wallace M, Ledent C, Jung KM, Piomelli D, Mackie K, Freund TF. 2006. Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci. 26:5628-5637.
47. Kawamura Y, Fukaya M, Maejima T, Yoshida T, Miura E, Watanabe M, Ohno-Shosaku T, Kano M. 2006. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci. 26:2991-3001.
48. Klausberger T, Marton LF, O'Neill J, Huck JH, Dalezios Y, Fuentealba P, Suen WY, Papp E, Kaneko T, Watanabe M, et al. 2005. Complementary roles of cholecystokinin-and parvalbumin-expressing GABAer-gic neurons in hippocampal network oscillations. J Neurosci. 25:9782-9793.
49. Lewis DA, Cruz D, Eggan S, Erickson S. 2004. Postnatal development of prefrontal inhibitory circuits and the pathophysiology of cognitive dysfunction in schizophrenia. Ann N Y Acad Sci. 1021:64-76.
50. Lewis DA, Cruz DA, Melchitzky DS, Pierri JN. 2001. Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the pre-frontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. Am J Psychiatry. 158:1411-1422.
51. Lewis DA, Hashimoto T, Volk DW. 2005. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci. 6:312-324.
52. 2 dopaminergic receptors in the developing cerebral cortex of macaque monkey: a film autoradiographic study. Neuroscience. 65:439-452.
53. Marsicano G, Lutz B. 1999. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci. 11:4213-4225.
54. Mato S, Del Olmo E, Pazos A. 2003. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Eur J Neurosci. 17:1747-1754.
55. Melchitzky DS, Sesack SR, Lewis DA. 1999. Parvalbumin-immunoreactive axon terminals in macaque monkey and human prefrontal cortex: laminar, regional and target specificity of type I and type II synapses. J Comp Neurol. 408:11-22.
56. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. 2007. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 370:319-328.
57. Morozov YM, Freund TF. 2003a. Postnatal development and migration of cholecystokinin-immunoreactive interneurons in rat hippocampus. Neuroscience. 120:923-939.
58. Morozov YM, Freund TF. 2003b. Post-natal development of type 1 cannabinoid receptor immunoreactivity in the rat hippocampus. Eur J Neurosci. 18:1213-1222.
59. Morozov YM, Torii M, Rakic P. 2009. Origin, early commitment, migratory routes, and destination of cannabinoid type 1 receptor-containing interneurons. Cereb Cortex. 1(Suppl 19):i78-i89.
60. Murray RM, Morrison PD, Henquet C, Di Forti M. 2007. Cannabis, the mind and society: the hash realities. Nat Rev Neurosci. 8:885-895.
61. Oeth KM, Lewis DA. 1993. Postnatal development of the cholecysto-kinin innervation of monkey prefrontal cortex. J Comp Neurol. 336:400-418.
62. Ohno-Shosaku T, Tsubokawa H, Mizushima I, Yoneda N, Zimmer A, Kano M. 2002. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J Neurosci. 22:3864-3872.
63. Pierri JN, Chaudry AS, Woo T-U, Lewis DA. 1999. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry. 156:1709-1719.
64. Pitler TA, Alger BE. 1992. Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells. J Neurosci. 12:4122-4132.
65. Plant TM. 1988. Neuroendocrine basis of puberty in the rhesus monkey (Macaca mulatta). In: Martini L, Ganong WF, editors. Frontiers in neuroendocrinology. Vol.10. New York: Raven Press. p. 215-238.
66. Romero J, GarciaPalomero E, Berrendero F, GarciaGil L, Hernandez ML, Ramos JA, Fernandezruiz JJ. 1997. Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse. 26:317-323.
67. Rosenberg DR, Lewis DA. 1995. Postnatal maturation of the dopami-nergic innervation of monkey prefrontal and motor cortices: a tyrosine hydroxylase immunohistochemical analysis. J Comp Neurol. 358:383-400.
68. Sundram S. 2006. Cannabis and neurodevelopment: implications for psychiatric disorders. Hum Psychopharmacol. 21:245-254.
69. Trettel J, Fortin DA, Levine ES. 2004. Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J Physiol. 556:95-107.
70. Uhlhaas PJ, Roux F, Singer W, Haenschel C, Sireteanu R, Rodriguez E. 2009. The development of neural synchrony reflects late maturation and restructuring of functional networks in humans. Proc Natl Acad Sci USA. 106:9866-9871.
71. Viveros MP, Llorente R, Moreno E, Marco EM. 2005. Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behav Pharmacol. 16:353-362.
72. Weickert CS, Webster MJ, Gondipalli P, Rothmond D, Fatula RJ, Herman MM, Kleinman JE, Akil M. 2007. Postnatal alterations in dopaminergic markers in the human prefrontal cortex. Neurosci-ence. 144:1109-1119.
73. Wilson RI, Nicoll RA. 2002. Endocannabinoid signaling in the brain. Science. 296:678-682.